As a Fort Worth Defective Drug Product Liability Attorney I am providing this update regarding the status of class actions lawsuits involving Prempro.
According to Bloomberg News, “Pfizer Inc.’s Wyeth unit properly warned a Virginia woman’s doctors about the risks of its Prempro menopause drug, the jury ruled in rejecting her claim for damages.”
Jurors found that “Georgia Torkie-Tork couldn’t show that Wyeth officials downplayed the breast-cancer risks associated with Prempro, a hormone-replacement drug.
The decision was Wyeth’s fourth straight victory in a Prempro suit weighed by a jury.”
Over “6 million women took Prempro and related menopause drugs to treat symptoms such as hot flashes and mood swings before a 2002 study highlighted their links to cancer.”